GenomOncology

View the org chart displaying its 10 main executives

Most searched biographies at GenomOncology

• Bradley Wertz, Chairman and Chief Executive Officer
• Len Pagon, Director
• Brian Laden, Board Member

Popular executive movements at GenomOncology

• Garreth Hippe has joined the company as Chief Commercial Officer  (posted on October 4 2023).

Create your alert
to follow the executive moves at GenomOncology.

GenomOncology has 2,274 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by GenomOncology

• GO Press Releases — Precision Oncology Solutions | GenomOncology
• HPL Selects Pathology Workbench | GenomOncology
• Northwestern Partnership | GenomOncology

Social media about GenomOncology

• GenomOncology on Wikipedia, Google News & Yahoo Finance
• GenomOncology on LinkedIn, Twitter & YouTube

Contact by email its executives including Bradley Wertz

Call GenomOncology at +1 440...

View the org chart

Register to receive your alert

Report an error